Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma. Journal of Carcinogenesis, [S. l.], v. 24, n. 8s, p. 553–562, 2025. DOI: 10.64149/J.Carcinog.24.8s.553-562. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1319. Acesso em: 26 dec. 2025.